The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-Small Cell Lung Cancer Patients Treated With Definitive Chemoradiation
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00281
Full Text
Open PDFAbstract
Available in full text
Date
July 27, 2018
Authors
Publisher
Frontiers Media SA